92 related articles for article (PubMed ID: 12804983)
1. Immunohistochemical study of nerve fibres in basal cell carcinoma.
Panuncio A; Vignale R; Lopez G
Eur J Dermatol; 2003; 13(3):250-3. PubMed ID: 12804983
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical characterization of the differentiation state of basal cell carcinomas with special interest for infiltrating relapsing tumors.
Barbaud A; Simon M; Parache RM; Serre G
Eur J Dermatol; 1998; 8(5):320-4. PubMed ID: 9683887
[TBL] [Abstract][Full Text] [Related]
3. The detection of basal cell determinants in human basal cell carcinomas using two different monoclonal antibodies.
Habets JM; Tank B; Vuzevski VD; van Reede EC; Stolz E; van Joost T
Acta Derm Venereol; 1987; 67(5):391-8. PubMed ID: 2448989
[TBL] [Abstract][Full Text] [Related]
4. Expression of p53 in aggressive and non-aggressive histologic variants of basal cell carcinoma.
Ansarin H; Daliri M; Soltani-Arabshahi R
Eur J Dermatol; 2006; 16(5):543-7. PubMed ID: 17101476
[TBL] [Abstract][Full Text] [Related]
5. [Proliferating patterns of basal cell carcinoma--immunohistological study by means of anti-BrdU monoclonal antibody].
Yoshimura K; Egawa K; Ono T
Nihon Hifuka Gakkai Zasshi; 1990 Apr; 100(5):575-80. PubMed ID: 2395219
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of immunohistochemical markers with invasiveness and histologic differentiation in squamous cell carcinoma and basal cell carcinoma of the skin.
Son KD; Kim TJ; Lee YS; Park GS; Han KT; Lim JS; Kang CS
J Surg Oncol; 2008 Jun; 97(7):615-20. PubMed ID: 18404670
[TBL] [Abstract][Full Text] [Related]
7. [Specific characteristics of skin basal cell carcinoma invasion].
Doĭkova NG; Chernyĭ AP; Chipysheva TA; Gel'shteĭn VI
Arkh Patol; 2000; 62(3):29-33. PubMed ID: 10897434
[TBL] [Abstract][Full Text] [Related]
8. Aggressive basal cell carcinoma in young patients: fact or fiction?
Milroy CJ; Horlock N; Wilson GD; Sanders R
Br J Plast Surg; 2000 Jul; 53(5):393-6. PubMed ID: 10876275
[TBL] [Abstract][Full Text] [Related]
9. Absence of cytokeratin 8 and inconsistent expression of cytokeratins 7 and 19 in human basal cell carcinoma.
Habets JM; Tank B; Vuzevski VD; Brevé J; Stolz E; van Joost T
Anticancer Res; 1988; 8(4):611-6. PubMed ID: 2460019
[TBL] [Abstract][Full Text] [Related]
10. Expression of cytokeratin 8 in basal cell carcinoma: a comparative immunohistochemical and immunoelectron microscopy study.
Kooy AJ; Tank B; de Jong TA; Vuzevski VD; Bosman FT; van Joost T
Anticancer Res; 1996; 16(1):277-82. PubMed ID: 8615621
[TBL] [Abstract][Full Text] [Related]
11. Basal cell carcinoma treated with Mohs surgery in Australia III. Perineural invasion.
Leibovitch I; Huilgol SC; Selva D; Richards S; Paver R
J Am Acad Dermatol; 2005 Sep; 53(3):458-63. PubMed ID: 16112353
[TBL] [Abstract][Full Text] [Related]
12. [Immunomorphological features of cutaneous basal-cell carcinoma].
Chuprov IN
Vopr Onkol; 2008; 54(6):715-9. PubMed ID: 19241845
[TBL] [Abstract][Full Text] [Related]
13. CD10 expression in trichoepithelioma and basal cell carcinoma.
Pham TT; Selim MA; Burchette JL; Madden J; Turner J; Herman C
J Cutan Pathol; 2006 Feb; 33(2):123-8. PubMed ID: 16420307
[TBL] [Abstract][Full Text] [Related]
14. Histological and immunohistochemical evaluation of basal cell carcinoma following curettage and electrodessication.
Filho LL; de Oliveira de Avelar Alchorne A; Pereira GC; Lopes LR; de Carvalho TC
Int J Dermatol; 2008 Jun; 47(6):610-4. PubMed ID: 18477158
[TBL] [Abstract][Full Text] [Related]
15. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2.
Zagrodnik B; Kempf W; Seifert B; Müller B; Burg G; Urosevic M; Dummer R
Cancer; 2003 Dec; 98(12):2708-14. PubMed ID: 14669293
[TBL] [Abstract][Full Text] [Related]
16. Perineural invasion in aggressive skin carcinomas of the head and neck. Potentially dangerous but frequently overlooked.
Cernea CR; Ferraz AR; de Castro IV; Sotto MN; Logullo AF; Bacchi CE; Plopper C; Wanderlei F; de Carlucci D; Hojaij FC
ORL J Otorhinolaryngol Relat Spec; 2009; 71(1):21-6. PubMed ID: 18946230
[TBL] [Abstract][Full Text] [Related]
17. Basal cell carcinoma treated with Mohs surgery in Australia I. Experience over 10 years.
Leibovitch I; Huilgol SC; Selva D; Richards S; Paver R
J Am Acad Dermatol; 2005 Sep; 53(3):445-51. PubMed ID: 16112351
[TBL] [Abstract][Full Text] [Related]
18. Characteristic Ber-EP4 and EMA expression in sebaceoma is immunohistochemically distinct from basal cell carcinoma.
Fan YS; Carr RA; Sanders DS; Smith AP; Lazar AJ; Calonje E
Histopathology; 2007 Jul; 51(1):80-6. PubMed ID: 17593083
[TBL] [Abstract][Full Text] [Related]
19. [Basal cell and basosquamous carcinomas of the external ear. Immunohistochemical study].
Croce A; Bianchedi M; Neri G; Moretti A; Angelucci D
Acta Otorhinolaryngol Ital; 1994; 14(4):367-75. PubMed ID: 7817742
[TBL] [Abstract][Full Text] [Related]
20. Basal cell carcinoma with ductal and glandular differentiation: a clinicopathological and immunohistochemical study of 10 cases.
Misago N; Satoh T; Narisawa Y
Eur J Dermatol; 2004; 14(6):383-7. PubMed ID: 15564201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
